Compass Ion Advisors, LLC United Therapeutics Corp Transaction History
Compass Ion Advisors, LLC
- $759 Million
- Q3 2024
A detailed history of Compass Ion Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Compass Ion Advisors, LLC holds 2,687 shares of UTHR stock, worth $960,978. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,687
Previous 2,892
7.09%
Holding current value
$960,978
Previous $921,000
4.45%
% of portfolio
0.13%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding UTHR
# of Institutions
671Shares Held
42.3MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.58 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.13 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.02 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$800 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...